Endocannabinoids measurement in human saliva as potential biomarker of obesity.
<h4>Background</h4>The discovery of the endocannabinoid system and of its role in the regulation of energy balance has significantly advanced our understanding of the physiopathological mechanisms leading to obesity and type 2 diabetes. New knowledge on the role of this system in humans...
Guardado en:
Autores principales: | Isabelle Matias, Blandine Gatta-Cherifi, Antoine Tabarin, Samantha Clark, Thierry Leste-Lasserre, Giovanni Marsicano, Pier Vincenzo Piazza, Daniela Cota |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aed1adebea0e4a59816beab0bdc55398 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biomarkers of endocannabinoid system activation in severe obesity.
por: Jack C Sipe, et al.
Publicado: (2010) -
Gut Microbiota and Mycobiota Evolution Is Linked to Memory Improvement after Bariatric Surgery in Obese Patients: A Pilot Study
por: Raphaël Enaud, et al.
Publicado: (2021) -
Endocannabinoids as potential biomarkers: It‘s all about pre-analytics
por: Daniel Kratz, et al.
Publicado: (2021) -
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.
por: John M McPartland, et al.
Publicado: (2014) -
Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids
por: Gianfranca Carta, et al.
Publicado: (2017)